323 related articles for article (PubMed ID: 32633781)
1. SOAT1 promotes mevalonate pathway dependency in pancreatic cancer.
Oni TE; Biffi G; Baker LA; Hao Y; Tonelli C; Somerville TDD; Deschênes A; Belleau P; Hwang CI; Sánchez-Rivera FJ; Cox H; Brosnan E; Doshi A; Lumia RP; Khaledi K; Park Y; Trotman LC; Lowe SW; Krasnitz A; Vakoc CR; Tuveson DA
J Exp Med; 2020 Sep; 217(9):. PubMed ID: 32633781
[TBL] [Abstract][Full Text] [Related]
2. KIF11 manipulates SREBP2-dependent mevalonate cross talk to promote tumor progression in pancreatic ductal adenocarcinoma.
Gu X; Zhu Q; Tian G; Song W; Wang T; Wang A; Chen X; Qin S
Cancer Med; 2022 Sep; 11(17):3282-3295. PubMed ID: 35619540
[TBL] [Abstract][Full Text] [Related]
3. p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression.
Moon SH; Huang CH; Houlihan SL; Regunath K; Freed-Pastor WA; Morris JP; Tschaharganeh DF; Kastenhuber ER; Barsotti AM; Culp-Hill R; Xue W; Ho YJ; Baslan T; Li X; Mayle A; de Stanchina E; Zender L; Tong DR; D'Alessandro A; Lowe SW; Prives C
Cell; 2019 Jan; 176(3):564-580.e19. PubMed ID: 30580964
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity for Kras
Ma Y; Li Y; Ling S; Li X; Kong B; Hu M; Huang P
Biochem Biophys Res Commun; 2020 Jun; 526(4):880-888. PubMed ID: 32279996
[TBL] [Abstract][Full Text] [Related]
5. Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
Kaymak I; Maier CR; Schmitz W; Campbell AD; Dankworth B; Ade CP; Walz S; Paauwe M; Kalogirou C; Marouf H; Rosenfeldt MT; Gay DM; McGregor GH; Sansom OJ; Schulze A
Cancer Res; 2020 Jan; 80(2):189-203. PubMed ID: 31744820
[TBL] [Abstract][Full Text] [Related]
6. SOAT1 deficiency attenuates atherosclerosis by regulating inflammation and cholesterol transportation via HO-1 pathway.
Wu N; Li RQ; Li L
Biochem Biophys Res Commun; 2018 Jun; 501(2):343-350. PubMed ID: 29567472
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.
Guillaumond F; Bidaut G; Ouaissi M; Servais S; Gouirand V; Olivares O; Lac S; Borge L; Roques J; Gayet O; Pinault M; Guimaraes C; Nigri J; Loncle C; Lavaut MN; Garcia S; Tailleux A; Staels B; Calvo E; Tomasini R; Iovanna JL; Vasseur S
Proc Natl Acad Sci U S A; 2015 Feb; 112(8):2473-8. PubMed ID: 25675507
[TBL] [Abstract][Full Text] [Related]
8. Cholesterol esterification inhibition and gemcitabine synergistically suppress pancreatic ductal adenocarcinoma proliferation.
Li J; Qu X; Tian J; Zhang JT; Cheng JX
PLoS One; 2018; 13(2):e0193318. PubMed ID: 29489864
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of SOAT1 Suppresses Glioblastoma Growth via Blocking SREBP-1-Mediated Lipogenesis.
Geng F; Cheng X; Wu X; Yoo JY; Cheng C; Guo JY; Mo X; Ru P; Hurwitz B; Kim SH; Otero J; Puduvalli V; Lefai E; Ma J; Nakano I; Horbinski C; Kaur B; Chakravarti A; Guo D
Clin Cancer Res; 2016 Nov; 22(21):5337-5348. PubMed ID: 27281560
[TBL] [Abstract][Full Text] [Related]
10. Fatty acids abrogate the growth-suppressive effects induced by inhibition of cholesterol flux in pancreatic cancer cells.
Li Y; Amrutkar M; Finstadsveen AV; Dalen KT; Verbeke CS; Gladhaug IP
Cancer Cell Int; 2023 Nov; 23(1):276. PubMed ID: 37978383
[TBL] [Abstract][Full Text] [Related]
11. High-affinity SOAT1 ligands remodeled cholesterol metabolism program to inhibit tumor growth.
Wang Z; Wang M; Zhang M; Xu K; Zhang X; Xie Y; Zhang Y; Chang C; Li X; Sun A; He F
BMC Med; 2022 Aug; 20(1):292. PubMed ID: 35941608
[TBL] [Abstract][Full Text] [Related]
12. SOAT1 enhances lung cancer invasiveness by stimulating AKT-mediated mitochondrial fragmentation.
Mo Y; Lin L; Zhang J; Yu C
Biochem Cell Biol; 2022 Feb; 100(1):68-74. PubMed ID: 34670102
[TBL] [Abstract][Full Text] [Related]
13. Sterol O-acyltransferase 1 deficiency improves defective insulin signaling in the brains of mice fed a high-fat diet.
Xu N; Meng H; Liu TY; Feng YL; Qi Y; Zhang DH; Wang HL
Biochem Biophys Res Commun; 2018 May; 499(2):105-111. PubMed ID: 29453986
[TBL] [Abstract][Full Text] [Related]
14. Loss of Heterozygosity for
Ma Y; Ling S; Li Y; Hu M; Kong B; Huang P; Liu H
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743139
[TBL] [Abstract][Full Text] [Related]
15. Cilia loss sensitizes cells to transformation by activating the mevalonate pathway.
Deng YZ; Cai Z; Shi S; Jiang H; Shang YR; Ma N; Wang JJ; Guan DX; Chen TW; Rong YF; Qian ZY; Zhang EB; Feng D; Zhou QL; Du YN; Liu DP; Huang XX; Liu LM; Chin E; Li DS; Wang XF; Zhang XL; Xie D
J Exp Med; 2018 Jan; 215(1):177-195. PubMed ID: 29237705
[TBL] [Abstract][Full Text] [Related]
16. KrasG12D-LOH promotes malignant biological behavior and energy metabolism of pancreatic ductal adenocarcinoma cells through the mTOR signaling pathway.
Shen X; Chang LG; Hu MY; Yan D; Zhou LN; Ma Y; Ling SK; Fu YQ; Zhang SY; Kong B; Huang PL
Neoplasma; 2018; 65(1):81-88. PubMed ID: 29322792
[TBL] [Abstract][Full Text] [Related]
17. The interplay between mutant p53 and the mevalonate pathway.
Parrales A; Thoenen E; Iwakuma T
Cell Death Differ; 2018 Mar; 25(3):460-470. PubMed ID: 29238070
[TBL] [Abstract][Full Text] [Related]
18. P53 deficiency affects cholesterol esterification to exacerbate hepatocarcinogenesis.
Zhu Y; Gu L; Lin X; Zhou X; Lu B; Liu C; Li Y; Prochownik EV; Karin M; Wang F; Li Y
Hepatology; 2023 May; 77(5):1499-1511. PubMed ID: 35398929
[TBL] [Abstract][Full Text] [Related]
19. Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways.
Brandi J; Dando I; Pozza ED; Biondani G; Jenkins R; Elliott V; Park K; Fanelli G; Zolla L; Costello E; Scarpa A; Cecconi D; Palmieri M
J Proteomics; 2017 Jan; 150():310-322. PubMed ID: 27746256
[TBL] [Abstract][Full Text] [Related]
20. High expression of Sterol-O-Acyl transferase 1 (SOAT1), an enzyme involved in cholesterol metabolism, is associated with earlier biochemical recurrence in high risk prostate cancer.
Eckhardt C; Sbiera I; Krebs M; Sbiera S; Spahn M; Kneitz B; Joniau S; Fassnacht M; Kübler H; Weigand I; Kroiss M
Prostate Cancer Prostatic Dis; 2022 Sep; 25(3):484-490. PubMed ID: 34326474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
